Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
Aim: To search for additional molecular-biological markers of cancer stem cell (CSC) involved in the development of intra-tumor heterogeneity for the detection of features of the breast cancer (BC) pathogenesis. Materialts and Methods: Expression of estrogen receptors (ER), progesterone receptors (P...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2017 |
| Main Authors: | Chekhun, V.F., Lukianova, N.Y., Chekhun, S.V., Bezdieniezhnykh, N.O., Zadvorniy, T.V., Borikun, T.V., Polishchuk, L.Z., Klyusov, O.M. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2017
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/138538 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer / V.F. Chekhun, N.Y. Lukianova, S.V. Chekhun, N.O. Bezdieniezhnykh, T.V. Zadvorniy, T.V. Borikun, L.Z. Polishchuk, O.М. Klyusov // Experimental Oncology. — 2017 — Т. 39, № 3. — С. 203-211. — Бібліогр.: 58 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)
by: S. V. Chekhun, et al.
Published: (2015)
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)
by: Ryspayeva, D.E., et al.
Published: (2017)
Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
by: I. P. Nesina, et al.
Published: (2019)
by: I. P. Nesina, et al.
Published: (2019)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: D. E. Ryspayeva
Published: (2018)
by: D. E. Ryspayeva
Published: (2018)
Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: Ryspayeva, D.E.
Published: (2018)
by: Ryspayeva, D.E.
Published: (2018)
Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy
by: Bereznaya, N.M., et al.
Published: (2007)
by: Bereznaya, N.M., et al.
Published: (2007)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Estimation of content of CD44+CD24– cells as additional criterion of efficiency of preventive therapy in experiment at oncopathology
by: N. A. Bondarovich, et al.
Published: (2008)
by: N. A. Bondarovich, et al.
Published: (2008)
Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)
by: Grybach, S.M., et al.
Published: (2018)
Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)
by: Grybach, S.M., et al.
Published: (2018)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Определение содержания CD44⁺CD24⁻ клеток как дополнительный критерий оценки эффективности превентивной терапии онкопатологии в эксперименте
by: Бондарович, Н.А., et al.
Published: (2008)
by: Бондарович, Н.А., et al.
Published: (2008)
Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
by: Chekhun, V.F., et al.
Published: (2023)
by: Chekhun, V.F., et al.
Published: (2023)
Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
by: Zadvornyi, T.V., et al.
Published: (2018)
by: Zadvornyi, T.V., et al.
Published: (2018)
Role of CD24 gene in tumor growth of different organs and study approaches
by: O. S. Hoister
Published: (2015)
by: O. S. Hoister
Published: (2015)
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)
by: Bereznaya, N.M., et al.
Published: (2008)
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
by: V. F. Chekhun, et al.
Published: (2016)
by: V. F. Chekhun, et al.
Published: (2016)
Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
by: L. A. Nalieskina, et al.
Published: (2018)
by: L. A. Nalieskina, et al.
Published: (2018)
MicroRNAs are a key factor in the globalization of tumor-host relationships
by: Chekhun, V.F.
Published: (2023)
by: Chekhun, V.F.
Published: (2023)
EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
by: L. M. Kovalevska, et al.
Published: (2019)
by: L. M. Kovalevska, et al.
Published: (2019)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
by: Chekhun, V.F., et al.
Published: (2009)
by: Chekhun, V.F., et al.
Published: (2009)
Innovative policy of european institutes in solving cancer problems. The General Assembly of OECI, Genoa, Italy, May 21–24
by: Chekhun, V.F.
Published: (2008)
by: Chekhun, V.F.
Published: (2008)
Molecular-genetic models for prognosis of development of tumors of reproductive system in women with family history of cancer
by: Paliychuk, O.V., et al.
Published: (2018)
by: Paliychuk, O.V., et al.
Published: (2018)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Effects of microbiotes on the development of human tumor pathologies
by: V. F. Chekhun, et al.
Published: (2020)
by: V. F. Chekhun, et al.
Published: (2020)
Similar Items
-
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015) -
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023) -
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018) -
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015) -
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)